JPH01224374A - エルゴリン誘導体 - Google Patents

エルゴリン誘導体

Info

Publication number
JPH01224374A
JPH01224374A JP1017416A JP1741689A JPH01224374A JP H01224374 A JPH01224374 A JP H01224374A JP 1017416 A JP1017416 A JP 1017416A JP 1741689 A JP1741689 A JP 1741689A JP H01224374 A JPH01224374 A JP H01224374A
Authority
JP
Japan
Prior art keywords
formula
tables
compound
formulas
acid addition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP1017416A
Other languages
English (en)
Japanese (ja)
Inventor
Roland Achini
ロランド・アチーニ
Rene Amstutz
レネ・アムシュツツ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of JPH01224374A publication Critical patent/JPH01224374A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP1017416A 1988-01-26 1989-01-25 エルゴリン誘導体 Pending JPH01224374A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3802178.1 1988-01-26
DE3802178 1988-01-26

Publications (1)

Publication Number Publication Date
JPH01224374A true JPH01224374A (ja) 1989-09-07

Family

ID=6345984

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1017416A Pending JPH01224374A (ja) 1988-01-26 1989-01-25 エルゴリン誘導体

Country Status (17)

Country Link
JP (1) JPH01224374A (fr)
KR (1) KR890011882A (fr)
AU (1) AU2872489A (fr)
DK (1) DK32389A (fr)
ES (1) ES2011986A6 (fr)
FI (1) FI890337A7 (fr)
FR (1) FR2626177B1 (fr)
GB (1) GB2214183A (fr)
GR (1) GR890100048A (fr)
HU (1) HUT51275A (fr)
IL (1) IL89063A0 (fr)
IT (1) IT1229537B (fr)
LU (1) LU87439A1 (fr)
NL (1) NL8900185A (fr)
PT (1) PT89518B (fr)
SE (1) SE8900256L (fr)
ZA (1) ZA89640B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4033496A1 (de) * 1990-10-20 1992-04-23 Sandoz Ag Neue ergolinderivate, ihre herstellung und verwendung
TW224091B (fr) * 1992-04-03 1994-05-21 Lilly Co Eli

Also Published As

Publication number Publication date
FR2626177B1 (fr) 1992-07-31
FR2626177A1 (fr) 1989-07-28
DK32389A (da) 1989-07-27
GB2214183A (en) 1989-08-31
FI890337A0 (fi) 1989-01-24
HUT51275A (en) 1990-04-28
ES2011986A6 (es) 1990-02-16
IT1229537B (it) 1991-09-04
IL89063A0 (en) 1989-08-15
LU87439A1 (fr) 1989-08-30
GB8901440D0 (en) 1989-03-15
KR890011882A (ko) 1989-08-23
PT89518A (pt) 1989-10-04
GR890100048A (el) 1994-03-31
ZA89640B (en) 1990-09-26
DK32389D0 (da) 1989-01-25
SE8900256L (sv) 1989-07-27
FI890337L (fi) 1989-07-27
PT89518B (pt) 1994-02-28
FI890337A7 (fi) 1989-07-27
NL8900185A (nl) 1989-08-16
IT8947562A0 (it) 1989-01-24
AU2872489A (en) 1989-07-27
SE8900256D0 (sv) 1989-01-25

Similar Documents

Publication Publication Date Title
JPS6354321A (ja) 血糖降下剤
JPS59106491A (ja) ベンゾキサジン化合物
JPH0273062A (ja) インドロン誘導体およびその製造法ならびにそれを含有する医薬
US4034113A (en) Treatment of senile geriatric patients to restore performance
CN113248524B (zh) 一种双吲哚生物碱化合物及其合成方法和用途
EP0507637A2 (fr) Utilisation de carboxamides benzobicycliques pour la fabrication d'un médicament pour l'utilisation comme analgésique
JPH05504360A (ja) オキソ―テトラヒドロピリダジニル―ピラゾロ［４，３―ｂ］―１，４―ベンズオキサジン
JPH01224374A (ja) エルゴリン誘導体
WO2008080290A1 (fr) Antagoniste selectif du recepteur m4 et utilisation medicale associee
DK169818B1 (da) Ergolinderivater, fremgangsmåde til fremstilling deraf, samt farmaceutisk præparat indeholdende disse
US4512994A (en) Long-acting theophylline in medicinal form
US12486250B2 (en) Muscarinic receptor 4 antagonists and methods of use
JPH0615553B2 (ja) ジヒドロピリジン−５−ホスホンアミド酸類
JPH0232081A (ja) α―アドレナリン作動性受容体拮抗剤
JPS59184162A (ja) キノリン誘導体、その製造法及び該化合物を含有する、５―ヒドロキシトリプタミン桔抗質として使用する医薬組成物
KR830001838B1 (ko) 페닐-퀴놀리지딘의 제조방법
JP2579116B2 (ja) 新規な４−メチル−１，３−オキサゾール化合物、それらの調製法およびそれらを含む医薬組成物
JPH11504616A (ja) ジベンズ［ｃｄ，ｆ］インドール誘導体
JPS642088B2 (fr)
JPS63233992A (ja) ジヒドロピリジン−５−ホスホン酸環状エステル類
SU1498391A3 (ru) Способ получени производных фуробензоксазола
US3337623A (en) Cyanamide derivatives of tetrahydrodibenzo[a, d]cyclooctene
EP0573548A1 (fr) Agents neuroprotecteurs.
JPH04257583A (ja) エルゴリン誘導体
JPH02221274A (ja) 新規な誘導体類